Doctor Jonathan Tjerkaski
Karolinska Institute, Stockholm (Sweden)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
The effect of Glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease
Event: ESC Congress 2024
Topic: Antidiabetic Pharmacotherapy
Session: Diabetes, obesity, and the heart
Comparison of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in myocardial infarction patients with type 2 diabetes
Event: ESC Congress 2023
Topic: Pharmacotherapy
Session: Treatment of acute coronary syndromes in clinical practice
Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: The role of bleeding in determining antithrombotic treatment in acute coronary syndromes
